G01N 2800/222
Platelet disorders
G01N2800/222 (Platelet disorders) appears on 66 US grants and 128 published applications in this corpus.
Search patents in G01N- Granted patents
- 66
- Published applications
- 128
- Assignees
- 102
- Inventors
- 239
- Latest grant
- 13 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 1 | 6 |
| 2007 | 0 | 6 |
| 2008 | 0 | 3 |
| 2009 | 1 | 3 |
| 2010 | 0 | 12 |
| 2011 | 3 | 4 |
| 2012 | 4 | 11 |
| 2013 | 4 | 4 |
| 2014 | 1 | 3 |
| 2015 | 7 | 13 |
| 2016 | 6 | 7 |
| 2017 | 4 | 2 |
| 2018 | 6 | 9 |
| 2019 | 5 | 5 |
| 2020 | 4 | 4 |
| 2021 | 2 | 8 |
| 2022 | 6 | 5 |
| 2023 | 2 | 7 |
| 2024 | 2 | 5 |
| 2025 | 6 | 7 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Antibodies that specifically bind peptides associated with the primary immunodeficiencies: Wiskott-Aldrich syndrome and x-linked agammaglobulinemia13 Jan 2026US 12,523,662 B2Seattle Children's Hospital
- Double deamidated form of Bcl-xL is a biomarker of platelet age11 Nov 2025US 12,467,924 B2Centre National De La Recherche Scientifique
- Method for preparing a sample2 Sep 2025US 12,405,279 B2B.R.A.H.M.S GmbH
- Identification of platelet activating antibodies22 Jul 2025US 12,366,584 B2Retham Technologies, Inc.
- Atomic description of immune complex that causes heparin-induced thrombocytopenia22 Apr 2025US 12,282,028 B2The Trustees of the University of Pennsylvania
- Methods and Devices for Detecting Mechanical Forces Using Cas Nuclease and Guide RNA Complexes18 Jun 2026US 2026/0168007 A1Emory University
- Reagent and method for diagnosing thrombotic events22 Jan 2026US 2026/0023088 A1Biokit Research & Development S.L.U.
- Compositions and methods for assaying platelet reactivity and treatment selection30 Oct 2025US 2025/0334575 A1University of Vermont and State Agricultural College
- Novel assay for the platelet binding activity of the von willebrand factor25 Sep 2025US 2025/0298041 A1
- Identification of prothrombotic conditions21 Aug 2025US 2025/0264483 A1Sydney Local Health District
Most cited
By later US patents
- Methods for measuring platelet reactivity of individuals treated with drug eluting stents15US 9,506,938 B2Accumetrics, Inc. · 2016
- Direct fluorescence-conjugated immunoassay for platelet activation12US 5,529,902 AMayo Foundation for Medical Education and Research · 1996
- System and method for a biomimetic fluid processing10US 9,795,965 B2The Brigham and Women S Hospital, Inc. · 2017
- Methods and kits for determining von Willebrand factor activity in the absence of ristocetin and for determining the activity of ADAMTS-13 protease7US 8,932,820 B2Siemens Healthcare Diagnostics Products GmbH · 2015
- System and method for a biomimetic fluid processing5US 10,343,163 B2President and Fellows of Harvard College · 2019